UTHR News and Press, United Therapeutics Corporation From 11/25/23

2023-11-25 03:20:10 ET Summary Latest revenue results are not favorable for MannKind nor United. MannKind needs to decide if Afrezza will be a reliable source of revenue or a drag on future revenues. United has been an unreliable partner for future use of MannKind's technology...

2023-11-09 11:12:02 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips If you’re a fan of the hit TV show Shark Tank , you’ve probably come across the intriguing term “unicorn” companies. Indeed, these fantastical entities are not o...

2023-11-08 14:42:48 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips In October, I warned investors that flying car firm EHang (NASDAQ: EH ) had an order book that looked suspiciously weak : During the most recent quarter, EHang delivered j...

2023-11-07 11:20:54 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips EHang (NASDAQ: EH ) stock is taking a plunge after Hindenburg Research published a short report on the Chinese electric vertical take-off and landing (eVTOL) company. In...

2023-11-01 14:38:07 ET United Therapeutics Corporation (UTHR) Q3 2023 Earnings Conference Call November 1, 2023 9:00 AM ET Company Participants Dewey Steadman – Head of Investor Relations Martine Rothblatt – Chairperson and Chief Executive Officer M...

Hitachi Construction Machinery Co. Ltd ADR (HTCMY) is expected to report for Q2 2024 DigitalBridge Group Inc. (DBRG) is expected to report $0 for Q3 2023 LY Corp ADR (YAHOY) is expected to report for Q2 2024 DT Midstream Inc. (DTM) is expected to report $0.9 for Q3 2023 Summit Mat...

2023-11-01 06:04:01 ET More on United Therapeutics United Therapeutics Shifts Focus To Tyvaso DPI Amidst Generic Threat United Therapeutics: Both Fundamental And Technical Analyses Justify A Buy Decision United Therapeutics: Eyeing A Re-Rating To 12-13x P/E, Growth M...

United Therapeutics Corporation (Nasdaq: UTHR ), a public benefit corporation, today announced its financial results for the quarter ended September 30, 2023. Total revenues in the third quarter of 2023 grew 18% year-over-year to $609.4 million, compared to $516.0 million in the third quarter...

United Therapeutics Corporation (UTHR) is expected to report $4.89 for Q3 2023

2023-11-01 04:17:37 ET More on United Therapeutics United Therapeutics Shifts Focus To Tyvaso DPI Amid Generic Threat United Therapeutics: Fundamental, Technical Analyses Justify A Buy Decision United Therapeutics Q3 2023 Earnings Preview United Therapeutics ...